These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2870085)
21. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade. Reilly CS; Wood M; Koshakji RP; Wood AJ Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029 [TBL] [Abstract][Full Text] [Related]
22. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings. Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341 [TBL] [Abstract][Full Text] [Related]
23. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. Sugiyama A; Takahara A; Hashimoto K J Cardiovasc Pharmacol; 1999 Jul; 34(1):70-7. PubMed ID: 10413070 [TBL] [Abstract][Full Text] [Related]
24. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. Barbier GH; Shettigar UR; Appunn DO Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691 [TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug. Frishman W Am Heart J; 1980 Jan; 99(1):124-8. PubMed ID: 6101295 [No Abstract] [Full Text] [Related]
27. Basic pharmacology of esmolol. Gorczynski RJ Am J Cardiol; 1985 Oct; 56(11):3F-13F. PubMed ID: 2864846 [TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias. Byrd RC; Sung RJ; Marks J; Parmley WW J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193 [TBL] [Abstract][Full Text] [Related]
29. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148 [TBL] [Abstract][Full Text] [Related]
30. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol. Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492 [TBL] [Abstract][Full Text] [Related]